[go: up one dir, main page]

SE8305667D0 - ADENOCARCINOMA RELATED NEW ANTIGENIC DETERMINANTS AND ANTIBODIES SPECIFIC THERETO, PROCESSES FOR THEIR PREPARATION AND REAGENT SYSTEMS PERTAINING TO THEM - Google Patents

ADENOCARCINOMA RELATED NEW ANTIGENIC DETERMINANTS AND ANTIBODIES SPECIFIC THERETO, PROCESSES FOR THEIR PREPARATION AND REAGENT SYSTEMS PERTAINING TO THEM

Info

Publication number
SE8305667D0
SE8305667D0 SE8305667A SE8305667A SE8305667D0 SE 8305667 D0 SE8305667 D0 SE 8305667D0 SE 8305667 A SE8305667 A SE 8305667A SE 8305667 A SE8305667 A SE 8305667A SE 8305667 D0 SE8305667 D0 SE 8305667D0
Authority
SE
Sweden
Prior art keywords
antigenic determinants
processes
preparation
antibodies specific
reagent systems
Prior art date
Application number
SE8305667A
Other languages
Swedish (sv)
Other versions
SE8305667L (en
Inventor
A Bartorelli
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE8305667D0 publication Critical patent/SE8305667D0/en
Publication of SE8305667L publication Critical patent/SE8305667L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method suitable for the diagnosis of human adenocarcinomas is described. In the method, antigenic material which is related to adenocarcinomas is determined in a sample which is taken from a human patient. The material in the sample is determined by using (a) anti-K antibodies or (b) anti-P<k> antibodies, using (a') exclusively those antigenic determinants K which are specific for adenocarcinomas, or (b') those antigenic determinants P<k> which with the K determinants are specific for adenocarcinomas.
SE8305667A 1983-06-23 1983-10-14 ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF SE8305667L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838317022A GB8317022D0 (en) 1983-06-23 1983-06-23 Adenocarcinoma related new antigenic determinants

Publications (2)

Publication Number Publication Date
SE8305667D0 true SE8305667D0 (en) 1983-10-14
SE8305667L SE8305667L (en) 1984-12-24

Family

ID=10544654

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305667A SE8305667L (en) 1983-06-23 1983-10-14 ADENOCARCIN-RELATED NEW ANTIGENA DETERMINANTS AND ANTIBODIES SPECIFIC TO THESE, PROCEDURE FOR THEIR PREPARATION AND REAGENT SYSTEM THEREOF

Country Status (13)

Country Link
JP (1) JPS6018765A (en)
AU (1) AU2017183A (en)
BE (1) BE899484A (en)
DE (1) DE3337465A1 (en)
DK (1) DK476083A (en)
FI (1) FI833742A (en)
FR (1) FR2548901A1 (en)
GB (1) GB8317022D0 (en)
IT (1) IT1194429B (en)
NL (1) NL8303571A (en)
NO (1) NO833756L (en)
SE (1) SE8305667L (en)
ZA (1) ZA837673B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589630B2 (en) * 1992-06-12 1997-03-12 ゼニヤ海洋サービス株式会社 Water control device for sabo dam

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
EP0072902B1 (en) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
DE3230299A1 (en) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt CARCINOEMBRYONALES ANTIGEN, METHOD FOR ITS INSULATION AND ITS USE

Also Published As

Publication number Publication date
AU2017183A (en) 1985-01-03
FR2548901A1 (en) 1985-01-18
JPS6018765A (en) 1985-01-30
GB8317022D0 (en) 1983-07-27
IT1194429B (en) 1988-09-22
NL8303571A (en) 1985-01-16
BE899484A (en) 1984-10-22
ZA837673B (en) 1984-08-29
DE3337465A1 (en) 1985-01-03
FI833742A0 (en) 1983-10-14
NO833756L (en) 1984-12-27
IT8323351A0 (en) 1983-10-19
SE8305667L (en) 1984-12-24
FI833742A (en) 1984-12-24
DK476083D0 (en) 1983-10-14
DK476083A (en) 1984-12-24

Similar Documents

Publication Publication Date Title
ATE6312T1 (en) METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF BASAL MEMBRANE MATERIAL, SUITABLE BASAL MEMBRANE FRAGMENTS FOR THIS AND METHOD FOR THEIR PRODUCTION, RESPECTIVELY. RECOVERY.
DE3382190D1 (en) IMMUNOGENOUS PROTEIN OR PEPTIDE COMPLEX, METHOD FOR PRODUCING THIS COMPLEX AND ITS USE AS IMMUNISTIMULANS AND AS A VACCINE.
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
DE3586440D1 (en) FOR THE DIAGNOSIS OF HUMAN STOMACH OR BREAST CANCER MONOCLONAL ANTIBODIES TO BE USED.
DK130791D0 (en) MONOCLONAL ANTIBODIES, ISAES FOR HB ALC.
IL68941A0 (en) Method for immobilizing biological materials,composite materials produced thereby and their use
AR243931A1 (en) Purified antigen, set of reagents for detecting anti-hiv-2 antibodies in a biological fluid that contains these antigens, antibodies, hybridomas and the procedures involved.
DE3750342D1 (en) Human gamma interferon-specific receptor protein, antibodies against this protein, methods for producing this protein and antibody and compositions containing this protein and antibody.
ATA208987A (en) IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS
OA08485A (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
DK304087A (en) HUMANT MONOCLONAL ANTIBODY AGAINST LUMPHADENOPATIA-ASSOCIATED VIRUS
FI870502A0 (en) Method for producing cross-protective human monoclonal antibodies and antibody-producing cell line
DE3583875D1 (en) METHOD FOR PRODUCING SPHERICAL WHOLE BLOOD ERYTHROCYTES AND FIXING THEREOF.
DK172686A (en) ANTIGEN DERIVED FROM HUMAN TISSUE, PROCEDURE FOR USING THE ANTIGEN TO MAKE MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF CANCER, PROCEDURE FOR DETECTION OF CANCER, AND OTHER
DE3689868D1 (en) Monoclonal antibodies to human plasma precallikrein and process for their preparation and use.
SE8205891D0 (en) ALFA-L ANTIBODY AND SET FOR PRODUCING THEREOF
SE8305667D0 (en) ADENOCARCINOMA RELATED NEW ANTIGENIC DETERMINANTS AND ANTIBODIES SPECIFIC THERETO, PROCESSES FOR THEIR PREPARATION AND REAGENT SYSTEMS PERTAINING TO THEM
EP0307476A4 (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
EP0269677A4 (en) TEST PROCEDURE AND ANTIBODIES FOR N-MYC PROTEINS.
FR2571146B1 (en) CARCINO-FETAL ANTIGENS OF HUMAN PANCREAS AND A PURIFICATION PROCESS, ANTISERUM AGAINST SUCH ANTIGENS AND ITS PREPARATION METHOD AND DIAGNOSTIC COMPOSITIONS CONTAINING THEM
ES2059539T3 (en) METHOD FOR THE PREVENTION OF GRAFT DISEASE AGAINST THE GUEST.
DE3682105D1 (en) SAMPLE, TRACERS, IMMUNOGENIC AND ANTIBODIES OF ETHOSUXIMID.
SE8403841L (en) BLOOD VINTAGE ROCK
EP0095502A4 (en) Human monoclonal antibodies or lymphokines in separation of cells or diagnosis of mammary cancer.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305667-1

Effective date: 19870501